Related content

A phase II study of UFT and leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer

By Gyldenkerne Niels   Glimelius Bengt   Frödin Jan Erik   Kjaer Mogens   Pfeiffer Per   Hansen Flemming   Keldsen Nina   Sandberg Erik   Jakobsen Anders  

Acta Oncologica, Vol. 43, Iss. 3, 2004-04 ,pp. : 276-279

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer

By Siemerink Ester   Drenth Annemieke   Mulder Nanno   Plukker John   Hospers Geke  

Gastric Cancer, Vol. 13, Iss. 2, 2010-06 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite

Epirubicin, cisplatin, oral UFT, and leucovorin combination chemotherapy in advanced and metastatic esophageal cancer

By Choi In   Seo Hee   Sung Hwa   Park Kyong   Kim Seok   Oh Sang   Seo Jae   Choi Chul   Kim Byung   Shin Sang   Kim Yeul   Kim Jun  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 33-37

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer

By Idelevich Efraim   Karminsky Natalie   Dinerman Michael   Katsenelson Rivka L.   Zvi Nana Ben   Baruch Noa Ben   Biran Haim   Man Sofia   Shani Adi  

Acta Oncologica, Vol. 46, Iss. 3, 2007-01 ,pp. : 324-329

Informa Healthcare

Access to resources Recommend Favorite

Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin - a randomised crossover trial in advanced colorectal cancer

By Borner M.M.   Schoffski P.   de Wit R.   Caponigro F.   Comella G.   Sulkes A.   Greim G.   Peters G.J.   van der Born K.   Wanders J.   de Boer R.F.   Martin C.   Fumoleau P.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 349-358

Elsevier

Access to resources Recommend Favorite